Dr. Trisha Kruger, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1550 S Pioneer Way Ste 365, Moses Lake, WA 98837 Phone: 509-793-9785 Fax: 509-764-3252 |
News Archive
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. announced today that it has submitted a New Drug Application to the U.S. Food and Drug Administration for rivaroxaban, an investigational, oral, once-daily anticoagulant, for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation.
"California regulators have fined hospitals just over $1 million for failing to report incidents such as leaving a foreign object in a patient after a surgery or operating on the wrong person, according to data released to California Watch by the California Department of Public Health."
Researchers at Vanderbilt University Medical Center and the University of Alberta in Canada have identified a biomarker for a cellular switch that accurately predicts which prostate cancer patients are likely to have their cancer recur or spread.
Heart attacks are more dangerous in the morning than at any other time of day, research has shown. The study has shown that compared with other times, patients who had an attack between 6am and noon suffered around 20% more damage to their hearts. Researchers say this pattern is thought to be linked to circadian rhythms, the 24-hour "body clock" processes that influence many biological functions including blood pressure.
› Verified 7 days ago